CREBBP, KMT2D, and EZH2 are thus frequent epigenetic hits, initially considered as direct tumor inducers regulating B-cell proliferation and differentiation, but now widely recognized for their additional role as modulators of lymphoma TME, in particular based on the data obtained in GEMM. This evidence concerns the gene EZH2 and lymphoma.